Literature DB >> 18343421

Potency preserving cystectomy with intrafascial prostatectomy for high risk superficial bladder cancer.

Paolo Puppo1, Carlo Introini, Franco Bertolotto, Angelo Naselli.   

Abstract

PURPOSE: We report the oncological and functional results of potency sparing cystectomy with intrafascial prostatectomy for high risk, superficial bladder cancer.
MATERIALS AND METHODS: A total of 37 patients underwent potency sparing cystectomy and orthotopic urinary substitution from 2001 to 2005. Inclusion criteria were age younger than 70 years, Charlson comorbidity index less than 2, high risk superficial bladder cancer, prostate specific antigen less than 4 ng/ml, free-to-total PSA ratio greater than 20% and normal digital rectal examination.
RESULTS: Median patient age was 58 years (range 52 to 66). Median followup was 35 months (range 24 to 71). One patient died of disease progression and 1 died of an unrelated cause. Of the 37 patients 35 (95%) were free of tumor. Daily continence was achieved in 36 patients (97.2%) and nighttime continence was achieved in 35 (95%). Two patients (5%) needed clean intermittent catheterization. A total of 35 patients (95%) stated that they maintained erectile function, including 28 (76%) without oral drugs. A significant decrease in the median International Index of Erectile Function score from baseline was noted 2 years after surgery (25 vs 21). A total of 32 patients (86%) had an International Index of Erectile Function score of greater than 17 at 2 years after cystectomy. Median scores on the International Continence Society male short form questionnaires did not show any significant difference before and after surgery. Prostate specific antigen was lower than 0.2 ng/ml in all cases.
CONCLUSIONS: The main criticism about so-called sexuality sparing cystectomy has been the presence of consistent prostatic remnants. Performing intrafascial prostatectomy together with supra-ampullar cystectomy seems to warrant good functional results with while better preserving oncological safety.

Entities:  

Mesh:

Year:  2008        PMID: 18343421     DOI: 10.1016/j.juro.2008.01.046

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Prostate capsule sparing versus nerve sparing radical cystectomy for bladder cancer: results of a randomized, controlled trial.

Authors:  Bruce L Jacobs; Stephanie Daignault; Cheryl T Lee; Khaled S Hafez; Jeffrey S Montgomery; James E Montie; Jean E Humrich; Brent K Hollenbeck; David P Wood; Alon Z Weizer
Journal:  J Urol       Date:  2014-07-24       Impact factor: 7.450

2.  Assessment of long-term quality of life in patients with orthotopic neobladder followed for more than 5 years.

Authors:  Atsushi Takenaka; Isao Hara; Hideo Soga; Iori Sakai; Tomoaki Terakawa; Mototsugu Muramaki; Hideaki Miyake; Kazushi Tanaka; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2010-10-30       Impact factor: 2.370

3.  Fifteen-year single-centre experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients.

Authors:  R Colombo; F Pellucchi; M Moschini; A Gallina; R Bertini; A Salonia; P Rigatti; F Montorsi
Journal:  World J Urol       Date:  2015-01-11       Impact factor: 4.226

Review 4.  Current status of laparoscopic and robot-assisted nerve-sparing radical cystectomy in male patients.

Authors:  Jian Huang; Xinxiang Fan; Wen Dong
Journal:  Asian J Urol       Date:  2016-05-27

5.  Modified completely intrafascial radical cysprostatectomy for bladder cancer: a single-center, blinded, controlled study.

Authors:  Xiao Wang; Jia Guo; Lei Wang; Min Wang; Xiaodong Weng; Hui Chen; Xiuheng Liu
Journal:  BMC Cancer       Date:  2021-08-03       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.